Skip to main content
. 2022 Jul 4;13:935500. doi: 10.3389/fphar.2022.935500

TABLE 1.

Comparison of HP and PDIA3 levels in “cancer group”, “polyp group” and “group of healthy volunteers” (x ± s). *vs. cancer group vs. healthy volunteers (p < 0.05),**vs. polyp group vs. healthy volunteers (p > 0.05).

Group Number of Cases HP (μl/ml) PDIA3 (ng/ml)
Cancer group 88 164 ± 33* 74 ± 18*
Polyp group 77 137 ± 13** 61 ± 13**
Healthy volunteers 36 138 ± 8 58 ± 15
P 0.000 0.000